Medscape: New drug reduces tics in Tourette syndrome patients without major side effects

A new study shows that an investigational drug helps reduce tics and is safe for children with Tourette syndrome (TS).

TS, a neurological condition that causes sudden repetitive involuntary muscle movements and sounds known as tics, typically develops in childhood and worsens during adolescence.

Donald Gilbert, MD, study investigator, professor of pediatrics in the University of Cincinnati College of Medicine and a pediatric movement disorders and TS specialist at Cincinnati Children's Hospital Medical Center, told Medscape the study results seem to indicate that "help is on the way" for patients looking for an effective treatment for TS without side effects like weight gain, anxiety or depression.

"There may be a drug available with a new mechanism of action that is effective to suppress tics without causing weight gain or unwanted neuropsychiatric side effects," Gilbert said.

The study findings will be formally presented at the American Academy of Neurology 2022 annual meeting in April.

Read the Medscape article.

Featured photo at top courtesy of Pixabay.

Related Stories

1

High Court offers protections for therapy speech

April 5, 2026

Jennifer Bard, a professor in the Donald P. Klekamp College of Law and the UC Department of Internal Medicine, spoke with journalists about the US Supreme Court ruling granting first amendment protections for speech offered during therapy sessions.

3

On track: Hoffman Honors Scholar studies public transit

April 2, 2026

Public transit is where Zane Sawyer’s lifelong passion for travel meets his commitment to making an impact. The University of Cincinnati first-year geography major in the College of Arts & Sciences and member of the second cohort of Hoffman Honors Scholars (HHS) has hit the ground running, designing a research project intended to capture both how public transit works and how its users perceive it.